» Articles » PMID: 25861641

Factors Influencing the Eicosanoids Synthesis in Vivo

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Apr 11
PMID 25861641
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

External factors activate a sequence of reactions involving the reception, transduction, and transmission of signals to effector cells. There are two main phases of the body's reaction to harmful factors: the first aims to neutralize the harmful factor, while in the second the inflammatory process is reduced in size and resolved. Secondary messengers such as eicosanoids are active in both phases. The discovery of lipoxins and epi-lipoxins demonstrated that not all arachidonic acid (AA) derivatives have proinflammatory activity. It was also revealed that metabolites of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) such as resolvins, protectins, and maresins also take part in the resolution of inflammation. Knowledge of the above properties has stimulated several clinical trials on the influence of EPA and DHA supplementation on various diseases. However, the equivocal results of those trials prevent the formulation of guidelines on EPA and DHA supplementation. Prescription drugs are among the substances with the strongest influence on the profile and quantity of the synthesized eicosanoids. The lack of knowledge about their influence on the conversion of EPA and DHA into eicosanoids may lead to erroneous conclusions from clinical trials.

Citing Articles

Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation.

Cutolo E, Campitiello R, Di Dato V, Orefice I, Angstenberger M, Cutolo M Mar Drugs. 2025; 23(2).

PMID: 39997210 PMC: 11857744. DOI: 10.3390/md23020086.


Red blood cell transfusion-related dynamics of extracellular vesicles in intensive care patients: a prospective subanalysis.

Raeven P, Karlhofer K, Sztulman L, Brugger J, Hoetzenecker K, Domenig C Sci Rep. 2024; 14(1):911.

PMID: 38195728 PMC: 10776840. DOI: 10.1038/s41598-023-48251-w.


Red blood cell transfusion-related eicosanoid profiles in intensive care patients-A prospective, observational feasibility study.

Raeven P, Hagn G, Niederstaetter L, Brugger J, Bayer-Blauensteiner S, Domenig C Front Physiol. 2023; 14:1164926.

PMID: 37008004 PMC: 10060532. DOI: 10.3389/fphys.2023.1164926.


Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α.

Mann S, Hadad N, Nelson Holte M, Rothman A, Sathiaseelan R, Ali Mondal S Elife. 2020; 9.

PMID: 33289482 PMC: 7744101. DOI: 10.7554/eLife.59616.


Lipidomic analysis of cancer cells cultivated at acidic pH reveals phospholipid fatty acids remodelling associated with transcriptional reprogramming.

Urbanelli L, Buratta S, Logozzi M, Mitro N, Sagini K, Di Raimo R J Enzyme Inhib Med Chem. 2020; 35(1):963-973.

PMID: 32308048 PMC: 7191909. DOI: 10.1080/14756366.2020.1748025.


References
1.
Nowak J, FitzGerald G . Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J Clin Invest. 1989; 83(2):380-5. PMC: 303692. DOI: 10.1172/JCI113895. View

2.
Walther B, Clementsson C, Vallgren S, Ihse I, Akesson B . Fat malabsorption in patients before and after total gastrectomy, studied by the triolein breath test. Scand J Gastroenterol. 1989; 24(3):309-14. DOI: 10.3109/00365528909093052. View

3.
Hrelia S, Bordoni A, Celadon M, Turchetto E, Biagi P, Rossi C . Age-related changes in linoleate and alpha-linolenate desaturation by rat liver microsomes. Biochem Biophys Res Commun. 1989; 163(1):348-55. DOI: 10.1016/0006-291x(89)92142-6. View

4.
Kawashima Y, Kozuka H . Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol. Biochem J. 1989; 263(3):897-904. PMC: 1133515. DOI: 10.1042/bj2630897. View

5.
Arduini A, Mancinelli G, Ramsay R . Palmitoyl-L-carnitine, a metabolic intermediate of the fatty acid incorporation pathway in erythrocyte membrane phospholipids. Biochem Biophys Res Commun. 1990; 173(1):212-7. DOI: 10.1016/s0006-291x(05)81043-5. View